Allogene Therapeutics
ALLO
ALLO
181 hedge funds and large institutions have $2.25B invested in Allogene Therapeutics in 2021 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 82 increasing their positions, 29 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
181
Holders Change
+13
Holders Change %
+7.74%
% of All Funds
3.16%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.05%
New
41
Increased
82
Reduced
29
Closed
27
Calls
$4.69M
Puts
$4.68M
Net Calls
+$9K
Net Calls Change
-$11.9M
Top Buyers
| 1 |
Primecap Management
Pasadena,
California
|
$93.3M |
| 2 |
Morgan Stanley
New York
|
$29.5M |
| 3 |
BlackRock
New York
|
$183M |
| 4 |
SC
Sessa Capital
New York
|
$19.6M |
| 5 |
Renaissance Technologies
New York
|
$18.4M |
